Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Marie-Astrid Krarup has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP16176119

METHOD FOR THE PRODUCTION OF FACTOR VII POLYPEPTIDES

IPC classification:
A61K 38/48, C12N 9/64
Applicant:
Novo Nordisk Health Care AG
Agent:
Marie-Astrid Krarup, Novo Nordisk A/S
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature